Spots Global Cancer Trial Database for Local Anesthetic Treatment of Oral Pain in Patients With Mucositis
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Local Anesthetic Treatment of Oral Pain in Patients With Mucositis
Official Title: Clinical Trial With Lozenges as Local Anesthetic Treatment for Head/Neck Cancer Patients With Oral Mucositis
Study ID: NCT02252926
Conditions
Study Description
Brief Summary: Oral mucositis is a damage to the mucosa of the oral cavity and pharynx. It is a serious and painful adverse effect caused by the radio therapy and/or chemo therapy patients with head and neck cancer receive. The pain caused by oral mucositis can be difficult to treat as the current treatment with opioids is not sufficient and can cause adverse effects. Our hypothesis is that treatment with a local anesthetic lozenge with bupivacaine can reduce the oral pain caused by mucositis compared with the current standard treatment.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Department of Oncology, Rigshospitalet, Copenhagen, , Denmark
Department of Oncology, Herlev Hospital, Denmark, Herlev, , Denmark
Contact Details
Name: Claus A Kristensen, MD, PhD
Affiliation: Department of Oncology, Rigshospitalet, Denmark
Role: PRINCIPAL_INVESTIGATOR
Name: Jens Bentzen, MD
Affiliation: Department of Oncology Herlev Hospital, Denmark
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
